000 01081 a2200313 4500
005 20250517062929.0
264 0 _c20160829
008 201608s 0 0 eng d
022 _a1744-8409
024 7 _a10.1586/1744666X.2016.1112739
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYiu, Zenas Z N
245 0 0 _aInterleukin 17-A inhibition in the treatment of psoriasis.
_h[electronic resource]
260 _bExpert review of clinical immunology
_c2016
300 _a1-4 p.
_bdigital
500 _aPublication Type: Editorial
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
650 0 4 _aChronic Disease
650 0 4 _aClinical Trials as Topic
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aInterleukin-17
_ximmunology
650 0 4 _aPsoriasis
_ximmunology
650 0 4 _aReceptors, Interleukin-17
_ximmunology
700 1 _aGriffiths, Christopher E M
773 0 _tExpert review of clinical immunology
_gvol. 12
_gno. 1
_gp. 1-4
856 4 0 _uhttps://doi.org/10.1586/1744666X.2016.1112739
_zAvailable from publisher's website
999 _c25442264
_d25442264